CMS Doubles Up On Test Reimbursements, Will Pay Labs $100 Per Test For COVID-19 Clinical Diagnostic Assays
Compensation nearly double the current $51-per-test rate
Executive Summary
The US Medicare agency said on 15 April it will double its reimbursement rate for certain COVID-19 lab tests.
You may also be interested in...
Medicare Will Boost Physician Reimbursement For Sharing COVID-19 Clinical Trial Data
Participants in CMS's Quality Payment Program can earn credit to boost their Medicare reimbursements by reporting information from COVID-19 drug trials through a clinical trial repository or registry; NIH issues treatment guidelines for the coronavirus that are to be continuously updated.
US Clinical Labs To Lose Money On COVID-19 Testing Without $5Bn Set Aside In Third $1Tn Aid Bill
A $5bn emergency fund reimbursing US clinical laboratories for scaling up COVID-19 testing with lab-developed tests must be part of a $1tn Senate coronavirus aid and relief package, clinical lab group ACLA says. Other provisions already included in the draft bill address stockpiling of testing swabs, liability protection for medtech firms, a requirement for device makers to report supply chain shortages, the expanded use of telehealth, and preventing durable medical equipment payment reductions.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.